New immune profiling data confirms disease-modifying mechanism, reinforces earlier signals of fibrosis resolution, lung repair, and improved lung function LA JOLLA, CA, Jan. 08, 2026 (GLOBE NEWSWIRE) ...
The ROAR trial tested the hypothesis that returning familial hypercholesterolemia-associated genetic results leads to ...
Sourcing Journal on MSN
What the Denim Supply Chain Is Investing in 2026
While sustainability has traditionally been a key driver of innovation in the denim industry, companies in 2026 are ...
Emids, a technology services company focused on digital engineering, artificial intelligence (AI), and platform solutions for ...
Q4 2025 preliminary net product revenues from global sales of IMCIVREE® (setmelanotide) of approximately $57 million for the ...
A consortium comprising TotalEnergies, QatarEnergy and Italy’s Eni on Friday signed with Lebanonj an agreement for gas ...
A multi-stakeholder group focused on strengthening dengue prevention and control policies in Asia[1] recently highlighted the ...
The newly launched program builds on previously published, peer-reviewed clinical research ( link to full publication) demonstrating that surface acoustic wave micro-vibration technology applied to ...
Company to present at J.P. Morgan Healthcare Conference on Tuesday, Jan 13, 2026 -SAN FRANCISCO--(BUSINESS ...
Founder and Chief Executive Officer of AtaiBeckley, said: “Following the strategic combination of atai Life Sciences and Beckley Psytech completed last year and the recent corporate redomiciliation to ...
Treatment with semaglutide has been shown to reduce the total number of hospital admissions and the duration of stays in patients with established cardiovascular disease (CVD) and overweight or ...
A new report published today, ‘Private markets: Unknown unknowns’, by the cross-party House of Lords Financial Services ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback